Clinical impact of dpp-4 inhibitor on autonomic neuropathy followed up by SUDOSCAN
The utility of SUDOSCAN to diagnose diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy
The benefits of SUDOSCAN in early diagnosis of diabetic peripheral neuropathy reviewed in The Lancet
EASD 2019 poster: diabetic foot risk detection with SUDOSCAN
About Sudoscan
Impeto Medical is a medical device company part of WITHINGS company. Created in June 2005, its corporate headquarters are located close to Paris, France; the company is also present in San Diego, CA, USA.
COPYRIGHT 2005-2024 – IMPETO MEDICAL © All rights reserved.
More information
Contact info
Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
